Zhejiang Jolly Pharmaceutical Co.,LTD

Shenzhen Stock Exchange 300181.SZ

Zhejiang Jolly Pharmaceutical Co.,LTD Free Cash Flow Yield on January 27, 2025: 1.55%

Zhejiang Jolly Pharmaceutical Co.,LTD Free Cash Flow Yield is 1.55% on January 27, 2025, a -30.52% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Zhejiang Jolly Pharmaceutical Co.,LTD 52-week high Free Cash Flow Yield is 2.57% on February 02, 2024, which is 65.61% above the current Free Cash Flow Yield.
  • Zhejiang Jolly Pharmaceutical Co.,LTD 52-week low Free Cash Flow Yield is 1.27% on November 11, 2024, which is -17.74% below the current Free Cash Flow Yield.
  • Zhejiang Jolly Pharmaceutical Co.,LTD average Free Cash Flow Yield for the last 52 weeks is 1.60%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300181.SZ

Zhejiang Jolly Pharmaceutical Co.,LTD

CEO Mr. Tao Wang
IPO Date Feb. 22, 2011
Location China
Headquarters No. 388, Zhiyuan North Road
Employees 2,687
Sector Healthcare
Industries
Description

Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research, production, and marketing of Chinese medicinal products in China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co., Ltd. in 1998. Zhejiang Jolly Pharmaceutical Co., Ltd. was founded in 2000 and is based in Huzhou, China.

StockViz Staff

February 2, 2025

Any question? Send us an email